A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)

Clinical trial NCT06680817 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06680817
Sponsor: Hoffmann-La Roche
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Neovascular Age-related Macular Degeneration Diabetic Macular Edema

Start date: 2025-02-05
Primary completion: 2027-06-30
Enrollment: 850

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.